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Alec J. Coppen, born 1923, died on 15 March 2019
Alec Coppen, a Honorary Fellow of the Royal College of Psychiatrists has acted as director of the Medical Research Council Unit for Neuropsychiatric Research in Epsom England until 1988. Among his international colleagues he was always highly respected as a pioneering psychiatrist and psychopharmacologist credited with the discovery of the role of serotonin in the pathogenesis of depression. His seminal paper in the Lancet 1963 showed that tryptophan markedly potentiated the antidepressant action of MAOIs. He pursued the serotonin theory conducting numerous studies including studies of serotonin metabolites in post-mortem brains of depressed suicides that culminated in his 1967 paper in the British Journal of Psychiatry on the biochemistry of affective disorders that became a citation classic and made him a much honoured member of the international group of psychopharmacologists and biological psychiatrists, the CINP (Collegium Internationale Psychopharmacologicum). He acted as its president for the 17th annual CINP meeting in Kyoto in the year 1990. It is fair to state that the development of SSRI antidepressants have one origin in his work. He has published more than 500 papers and seven books on various studies of the biology of affective disorders. His other major contribution to the psychopharmacology of mood disorders was the establishment of the Lithium Clinic at West Park Hospital (in a chapter for a volume on the history of CINP he wrote: "One lesson we learned is that simply prescribing treatment is not effective"). He conducted the first placebo controlled trial of the effectiveness of lithium salts in the prophylaxis of recurrent mood disorders culminating in the discovery of lithium's unique anti-suicidal effects concurrently with two German research groups in Berlin and Dresden. He conducted a trial of the optimum dosage of lithium establishing its minimum effective dose for prophylaxis. He studied its adverse effects on renal and thyroid functions to establish standards for safe medical practice. His last paper was a review of the effectiveness of lithium in the long-term treatment of unipolar (recurrent) depression in 2017. Alec often talked about the many letters he received from patients and their families thanking him for his good care years after he retired.
Alec had been trained in psychiatry at the Maudsley Hospital where he started his research work in biological psychiatry and attained the MD in 1958. 
